Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Biogen Inc. (BIIB) had Free Cash Flow per Share of $13.94 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$2.28B |
|
$-48.90M |
|
$495.50M |
|
$1.78B |
|
$2.18B |
|
$98.40M |
|
$-154.40M |
|
$-56.00M |
|
$-56.00M |
|
$-48.90M |
|
$-48.90M |
|
$-48.90M |
|
$-48.90M |
|
$98.40M |
|
$423.40M |
|
146.50M |
|
147.10M |
|
$-0.33 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$8.97B |
|
$3.06B |
|
$20.47B |
|
$29.44B |
|
$3.35B |
|
$6.29B |
|
$7.83B |
|
$11.18B |
|
$18.26B |
|
$2.59B |
|
$18.26B |
|
146.70M |
|
| Cash Flow Statement Financials | |
$2.20B |
|
$-1.37B |
|
$-301.90M |
|
$2.38B |
|
$3.01B |
|
$633.50M |
|
$290.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.68 |
|
-- |
|
-- |
|
0.26 |
|
0.34 |
|
78.26% |
|
4.32% |
|
4.32% |
|
-- |
|
-2.46% |
|
-2.15% |
|
$2.05B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.23 |
|
1.70 |
|
53.00 |
|
-0.27% |
|
-1.89% |
|
-0.17% |
|
-0.20% |
|
$124.45 |
|
|
Free Cash Flow per Share |
$13.94 |
$14.99 |
|